Grading of hypervascular hepatocellular carcinoma using late phase of contrast enhanced sonography-A prospective study

Digestive and Liver Disease

Volumn 43, Issue 6, 2011, Pages 484-490

  Boozari, Bita ^a   Soudah, Bisharah ^a   Rifai, Kinan ^a   Schneidewind, Sabine ^a   Vogel, Arndt ^a   Hecker, Hartmut ^a   Hahn, Andreas ^a   Schlue, Jerome ^a   Dietrich, Christoph F ^b   Bahr, Matthias J ^a   Kubicka, Stefan ^a   Manns, Michael P ^a   Gebel, Michael ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b CARITAS KRANKENHAUS   (Germany)

Author keywords

Contrast enhanced ultrasound; Hepatocellular carcinoma; Tumour grading

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CLINICAL TRIAL; CONTRAST ENHANCED ULTRASONOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ECHOGRAPHY; FEMALE; HISTOLOGY; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PAIN; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SINGLE BLIND PROCEDURE; TUMOR BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; FEMALE; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY;

EID: 79955886119     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2011.01.001     Document Type: Article

References (32)

1. Raoul J.L. Natural history of hepatocellular carcinoma and current treatment options. Semin Nucl Med 2008, 38:S13-S18.
2. Pang R.W., Poon R.T. From molecular biology to targeted therapies for hepatocellular carcinoma: the future is now. Oncology 2007, 72(Suppl. 1):30-44.
3. Theise N.D., Park Y.N., Kojiro M. Dysplastic nodules and hepatocarcinogenesis. Clin Liver Dis 2002, 6:497-512.
4. Nicolau C., Catala V., Vilana R., et al. Evaluation of hepatocellular carcinoma using SonoVue, a second generation ultrasound contrast agent: correlation with cellular differentiation. Eur Radiol 2004, 14:1092-1099.
5. Schwartz M., Roayaie S., Konstadoulakis M. Strategies for the management of hepatocellular carcinoma. Nat Clin Pract Oncol 2007, 4:424-432.
6. Sotiropoulos G.C., Molmenti E.P., Losch C., et al. Meta-analysis of tumor recurrence after liver transplantation for hepatocellular carcinoma based on 1,198 cases. Eur J Med Res 2007, 12:527-534.
7. Kim S.H., Lim H.K., Choi D., et al. Percutaneous radiofrequency ablation of hepatocellular carcinoma: effect of histologic grade on therapeutic results. AJR Am J Roentgenol 2006, 186(5 Suppl.):S327-S333.
8. Bartolozzi C., Lencioni R., Caramella D., et al. The magnetic resonance and histological correlations in hepatocellular carcinoma. Radiol Med (Torino) 1994, 87:90-95.
9. Asayama Y., Yoshimitsu K., Nishihara Y., et al. Arterial blood supply of hepatocellular carcinoma and histologic grading: radiologic-pathologic correlation. AJR Am J Roentgenol 2008, 190:W28-W34.
10. Burns P.N., Wilson S.R. Focal liver masses: enhancement patterns on contrast-enhanced images-concordance of US scans with CT scans and MR images. Radiology 2007, 242:162-174.
11. Cosgrove D.O. A revolution in liver ultrasound. Eur J Gastroenterol Hepatol 2007, 19:1-2.
12. Fan Z.H., Chen M.H., Dai Y., et al. Evaluation of primary malignancies of the liver using contrast-enhanced sonography: correlation with pathology. AJR Am J Roentgenol 2006, 186:1512-1519.
13. Jang H.J., Kim T.K., Burns P.N., et al. Enhancement patterns of hepatocellular carcinoma at contrast-enhanced US: comparison with histologic differentiation. Radiology 2007, 244:898-906.
14. Ishak K., Baptista A., Bianchi L., et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995, 22:696-699.
15. Albrecht T., Blomley M., Bolondi L., et al. Guidelines for the use of contrast agents in ultrasound. January 2004. Ultraschall Med 2004, 25:249-256.
16. Claudon M., Cosgrove D., Albrecht T., et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) - update 2008. Ultraschall Med 2008, 29:28-44.
17. Nolte M., Werner M., Ewig M., et al. Demonstration of the Philadelphia translocation by fluorescence in situ hybridization (FISH) in paraffin sections and identification of aberrant cells by a combined FISH/immunophenotyping approach. Histopathology 1995, 26:433-437.
18. Wilkens L., Flemming P., Gebel M., et al. Induction of aneuploidy by increasing chromosomal instability during dedifferentiation of hepatocellular carcinoma. Proc Natl Acad Sci U S A 2004, 101:1309-1314.
19. Ishak K., Baptista A., Bianchi L., et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995, 22:696-699.
20. Strobel D., Kleinecke C., Hansler J., et al. Contrast-enhanced sonography for the characterisation of hepatocellular carcinomas-correlation with histological differentiation. Ultraschall Med 2005, 26:270-276.
21. Bolondi L. Screening for hepatocellular carcinoma in cirrhosis. J Hepatol 2003, 39:1076-1084.
22. Bolondi L., Gaiani S., Celli N., et al. Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology 2005, 42:27-34.
23. Gaiani S., Celli N., Piscaglia F., et al. Usefulness of contrast-enhanced perfusional sonography in the assessment of hepatocellular carcinoma hypervascular at spiral computed tomography. J Hepatol 2004, 41:421-426.
24. Ignee A., Weiper D., Schuessler G., et al. Sonographic characterisation of hepatocellular carcinoma at time of diagnosis. Z Gastroenterol 2005, 43:289-294.
25. Quaia E., D'Onofrio M., Cabassa P., et al. Diagnostic value of hepatocellular nodule vascularity after microbubble injection for characterizing malignancy in patients with cirrhosis. AJR Am J Roentgenol 2007, 189:1474-1483.
26. Pawlik T.M., Gleisner A.L., Anders R.A., et al. Preoperative assessment of hepatocellular carcinoma tumor grade using needle biopsy: implications for transplant eligibility. Ann Surg 2007, 245:435-442.
27. Iavarone M., Sangiovanni A., Forzenigo L.V., et al. Diagnosis of hepatocellular carcinoma in cirrhosis by dynamic contrast imaging: the importance of tumor cell differentiation. Hepatology 2010, 52:1723-1730.
28. Bruix J., Sherman M. Management of hepatocellular carcinoma. Hepatology 2005, 42:1208-1236.
29. Ceyhan K., Kupana S.A., Bektas M., et al. The diagnostic value of on-site cytopathological evaluation and cell block preparation in fine-needle aspiration cytology of liver masses. Cytopathology 2006, 17:267-274.
30. Soudah B., Marwedel M., Gebel M., et al. Feinnadelaspiration (FNA) der Leber und Gallengänge. Klinische Zytologie 2007, Zuckschwerdt, Müenchen wien New York.
31. Huang G.T., Sheu J.C., Yang P.M., et al. Ultrasound-guided cutting biopsy for the diagnosis of hepatocellular carcinoma-a study based on 420 patients. J Hepatol 1996, 25:334-338.
32. Longchampt E., Patriarche C., Fabre M. Accuracy of cytology vs. microbiopsy for the diagnosis of well-differentiated hepatocellular carcinoma and macroregenerative nodule. Definition of standardized criteria from a study of 100 cases. Acta Cytol 2000, 44:515-523.